Data comparing substitution with albumin and partial substitution with fresh frozen plasma during selective plasma exchange in ABO-incompatible kidney transplantation

Selective Plasma Exchange (SePE) is a type of plasma exchange in which the plasma separation membrane has a smaller pore size than conventional plasma separation membranes, so that small and medium molecular weight
substances can be removed, while larger molecular weight substances are not.

This dataset provides Clinical data from 30 ABO-incompatible kidney transplantation recipients before and after receiving SePE, and for patients receiving SePE using albumin alone versus partially using fresh frozen plasma (FFP).

The data are presented in a single .csv file with 16 columns. Columns headings are as follows:
- case_id: numerical identifier for 30 recipients of ABOi kidney transplantation
- session_id: SePE session. Group A (using albumin alone): n=41; Group F (partially using FFP): n=17
- TIME_pre1_post2: pre-transplant = 1; post-transplant = 2
- Alb_0orFFP_1: albumin alone = 0; fresh frozen plasma = 1
- Anticoa_NM_1: anticoagulant nafamostat mesilate (NM) used
- SePE_0orSePE+HD_1: SePE alone = 0; SePE plus hemodialysis (HD) = 1
- IgM_Titers: Concentration of serum IgM, determined by titer testing
- IgG_Titers: Concentration of serum IgG, determined by titer testing
- Fib: coagulation factor fibrinogen
- F13: coagulation factor XIII
- IgM: immunoglobulin M
- IgG: immunoglobulin G
- SBP: systolic blood pressure
- DBP: diastolic blood pressure
- PR: pulse rate
- Side-effects: had side-effects, such as rashes, nausea, abdominal pain, etc

The related manuscript describes a retrospective case-series study conducted on patients who underwent ABOi kidney transplantation at the Department of Urology, Osaka City University Hospital between January 2015 and December 2018. The aim of the study was to compare the clinical effects of SePE using albumin alone to SePE partially using FFP.